Migration of mononuclear cells in the modified boyden chamber as evaluated by DNA quantification and flow cytometry

Scandinavian Journal of Immunology

Volumn 52, Issue 3, 2000, Pages 257-263

  Ellingsen, ^a,b   Storgaard, ^a,b   MoLler ^a,b   Buus, ^a,b   Andersen, ^a,b   Obel, ^a,b   Stengaard Pedersen, ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOATTRACTANT; FORMYLMETHIONYLLEUCYLPHENYLALANINE;

CELL ADHESION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA CONTENT; DNA DETERMINATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; LYMPHOCYTE; MEMBRANE; MONONUCLEAR CELL; PARTICLE SIZE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVIEW;

ANTIGENS, CD; BLOOD PHYSIOLOGY; CHEMOTACTIC FACTORS; CHEMOTAXIS, LEUKOCYTE; CYTOLOGICAL TECHNIQUES; DNA; FLOW CYTOMETRY; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; MEMBRANES, ARTIFICIAL; MONOCYTES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; SYNOVIAL FLUID; T-LYMPHOCYTES; TIME FACTORS;

EID: 0033863078     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2000.00766.x     Document Type: Review

References (47)

1. The chemotactic effect of mixtures of antibody and antigen on polymorphnuclear leucocytes
2. A simple multiple chamber apparatus for measuring chemotaxis of polymorphonuclear leukocytes utilizing centrifugation of the chambers before incubation
3. 48-Well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration
4. Monocyte function in man
5. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes
6. Defective monocyte and polymorphonuclear leukocyte chemotaxis in atopic disease
7. Tumor-derived chemotactic factor(s) from human ovarian carcinoma: Evidence for a role in the regulation of macrophage content of neoplastic tissues
8. A human mononuclear leukocyte chemotactic factor: Characterization, specificity and kinetics of production by homologous leukocytes
9. Abnormal monocyte chemotactic response in cancer patients
10. Human mononuclear leukocyte chemotaxis: A quantitative assay for humoral and cellular chemotactic factors
11. The human cytokine I-309 is a monocyte chemoattractant
12. Detection of CD14 on migrated monocytes by specific antibody: A possible quantification for blood monocyte chemotaxis
13. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
14. Rantes, expression and contribution to monocyte chemotaxis in arthritis
15. Defective human mononuclear leukocyte chemotaxis as an index of host resistance to malignant melanoma
16. Production of monocyte chemotactic and activating factor (MCAF) by human dermal fibroblasts in response to interleukin 1 or tumor necrosis factor
17. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line
18. Defective mononuclear leukocyte chemotaxis in the Chediak-Higashi syndrome of humans, mink and cattle
19. Computer-assisted image analysis assay of human neutrophil chemotaxis in vitro
20. An improved multimembrane microassay for quantitating the motility of granulocytes and monocytes labeled with chromium-51
21. Use of a multiwell assembly for chemotaxis and evaluation by enzyme-linked immunosorbent assay (ELISA)
22. A rapid, multiwell colorimetric assay for chemotaxis
23. Depressed mononuclear leukocyte chemotaxis in thermally injured patients
24. Human T lymphocytes and T-cell lines as target cells for lymphocyte chemotaxis
25. An improved method for the in vitro evaluation of monocyte leukotaxis
26. A simple, rapid, and sensitive DNA assay procedure
27. DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water
28. Improved microfluorometric DNA determination in biological material using 33258 Hoechst
29. Assay for nanogram quantities of DNA in cellular homogenates
30. Simplified myeloperoxidase stain using benzidine dihydrochloride
31. Antibody-dependent monocyte-mediated cytotoxicity. The interference by platelets, immune complexes, and normal serum
32. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials
33. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis
34. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria
35. Analysis of clinical judgment helps to improve agreement in the assessment of rheumatoid arthritis
36. Grading of tenderness as a source of interrater error in the Ritchie articular index
37. An experiment in reducing interobserver variability of the examination for joint tenderness
38. Rheumatoid arthritis: Relation of serum C-reactive protein and erythrocyte sedimentation rates to radiographic changes
39. Radiographic outcome of recent onset rheumatoid arthritis, a 19 year study of radiographic progression
40. Tissue derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: Relationship to development of joint destruction in hands and feet
41. Validity and reliability of joint indices. A longitudinal study in patients with recent onset rheumatoid arthritis
42. Patterns of radiological progression in early rheumatoid arthritis: Results of an 8 year prospective study
43. Time lag between active joint inflammation and radiological progression in patients with early rheumatoid arthritis
44. The relation of radiographic changes to serum acute-phase proteins and rheumatoid factor in 200 patients with rheumatoid arthritis
45. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparaison of radiologic damage, physical disability, joint counts and acute phase reactants
46. In vitro migration of mononuclear cells towards synovial fluid and plasma from rheumatoid arthritis patients correlate to RANTES synovial fluid levels and to clinical pain parameters